Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Xiaolong Qi, Ian Homer et al.|Hepatology International|2020Cited by 295
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3Anjali Sibley, Samir M. Fakhry, Kwang‐Hyub Han et al.|Journal of Viral Hepatitis|2015Cited by 77
Impact of organ failure in patients with acute on chronic liver failure (ACLF) and the newly defined AARC liver failure score in predicting 90 days survival-results from APASAL-ACLF research consortium (AARC)Apurva Pande, S.K. Sarin, Ashok Choudhury et al.|Journal of Hepatology|2018Cited by 0
Hemophagocytic Lymphohistiocytosis (HLH) in patients of acute on chronic liver failure-Results of multination study from APASL-ACLF research consortium (AARC)Harsh Vardhan Tevethia, S.K. Sarin, Ashok Choudhury et al.|Journal of Hepatology|2018Cited by 0